Page 19 - Midatech Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020 Preliminary Results for the Year Ended 31 December 2020 ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 30, 2021 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the year ended 31 December 2020. Following the announcement of a Strategic Review in March 2020 and the termination of further in-house development of MTD201, the Company has broadened its R&D pipeline through tech...

Investegate announcements from ,

The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today. The applicable percentage is set by reference to a security's Millennium Exchan...

JNJ Single-shot COVID-19 Vaccine At FDA Altar, KPTI Expands Xpovio's Footprint, OTLK On Track NEW BRUNSWICK (dpa-AFX) - Today's Daily Dose brings you news about Johnson & Johnson seeking FDA nod for its single-shot COVID-19 vaccine candidate, T2 Biosystems' molecular diagnostic test detecting Brazil variant of the SARS-CoV-2 virus, Sientra' better-than-expected Q4 preliminary revenue results, Karyopharm securing approval for XPOVIO in Israel and resignation of Merck's CEO. Read on. 1. JNJ Seeks emergency FDA Nod For COVID-19 Vaccine Johnson & Johnson (JNJ) has submitted an application to the ...

Investegate announcements from Midatech Pharma PLC, Second Price Monitoring Extn